Efficacy and safety of Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 as an adjuvant for Helicobacter pylori eradication: a double-blind, randomized, placebo-controlled study

Efficacy and safety of Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 as an adjuvant for Helicobacter pylori eradication: a double-blind, randomized, placebo-controlled study

BackgroundHelicobacter pylori eradication is recommended as a way of providing symptomatic relief for dyspepsia. The limited efficacy of triple therapy is a major problem in many countries, including Thailand. Some probiotics have been shown to improve the H. pylori eradication rate and reduce side...

Full description

Bibliographic Details
Main Authors: Anya Kiattiweerasak, Natsuda Aumpan, Soonthorn Chonprasertsuk, Bubpha Pornthisarn, Sith Siramolpiwat, Patommatat Bhanthumkomol, Pongjarat Nunanan, Navapan Issariyakulkarn, Varocha Mahachai, Yoshio Yamaoka, Ratha-korn Vilaichone
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Gastroenterology
Subjects:
Helicobacter pylori
triple therapy
probiotic
gastritis
Thailand
Online Access:https://www.frontiersin.org/articles/10.3389/fgstr.2023.1245993/full

Internet

https://www.frontiersin.org/articles/10.3389/fgstr.2023.1245993/full

Similar Items